22 Feb Sky Medical Technology – part of DIT international showcase of UK Life Sciences innovators
The Department for International Trade (DIT) has named Sky Medical Technology part of their international showcase of UK exporters of innovative MedTech making waves globally.
Getting selected has allowed us to represent the UK at key overseas events, including being profiled in DIT campaigns in key overseas markets via their global network. It has helped us to further internationalise our business and reach new target customers, partners, investors, and markets.
Our expression of interest (to be considered by the DIT) won through on the pioneering role the geko™ device has played in reducing the risk of venous thromboembolisms (VTEs) – otherwise known as blood clots – in at-risk hospitalised patients across the UK.
“We are proud to be part of the DIT showcase of UK Life Sciences innovators. Together with our clinical partners across the NHS, we are helping transform healthcare for better patient outcomes and lower health system costs. The UK has a long-standing reputation as a powerhouse in life sciences, and we are enjoying playing our part in demonstrating this on the global stage,” said Bernard Ross, CEO at Sky Medical Technology.
Collaboration brings innovation
Around 55 – 60 percent of all VTE cases occurring during or following hospitalisation, resulting in approximately 40,000 deaths in England alone each year.
Our collaborative partnerships with adopters of innovation across the NHS span VTE prevention, pre and post-operative swelling reduction and chronic wound healing (leg ulcers) – and include game-changing partnerships with clinicians such as, Dr Indira Natarajan, Consultant Stroke Physician at the NHS Royal Stoke University Hospital, in his use of the geko™ device for post-stroke VTE prevention. His real-world data has influenced adoption of the geko™ device across the NHS.
The UK Life Science Innovator programme was setup to showcase the UK’s growing strengths in key areas such as diagnostics, medical devices and research and innovation, to an international network of healthcare professionals and investors.
As honourees, our team will now attend some of the world’s most prestigious healthcare events to showcase the geko™ device and enable more people to understand the clinically proven impact its neuromuscular electrostimulation (NMES) technology is having on patients suffering with conditions such as VTE, chronic wounds, and oedema.
An adventure at Arab Health
In fact, last month saw us attend the first of these showcase events: the Arab Health Conference in Dubai, United Arab Emirates, where we were joined by more than 60,000 healthcare professionals from more than 60 countries for a celebration of healthcare innovation. It was here that Andrew Bowie MP, the UK Minister for Exports, formally made the announcement of the companies chosen as Life Science Innovators 2023.
Mingling with fellow MedTech pioneers, our team shared more about how the geko™ device is being used across the region to treat and prevent acute post-operative and trauma-related oedema for enhanced patient recovery after surgery – including at the Al Hikma Hospital in Jordan.
As part of our venture to Arab Health, our EMEA Distribution Manager, Chris Walker, delivered a quickfire presentation on the geko™ device as part of the Innov8 programme for healthcare innovators, disruptors, and entrepreneurs.
Our travels will next see us head to Basel in Switzerland for the BIO-Europe Spring event in March, followed by the BIO International Convention in Boston in June.